About this event
GLP-1 medications like Ozempic and Wegovy are transforming the way people treat their health, wellness, and weight management. Hosted by Bill Giebler, Content & Insights Director at New Hope Network, and Melissa Dunn, EVP of Marketing & Communications at Suzy, this webinar will explore the latest findings from Suzy’s consumer data and from Nutrition Business Journal’s research report Supplements in the Ozempic Age.
Suzy’s GLP-1 tracker data found that 58% of early adopters avoided sugars in their diet, while only 33% of more recent users made the same claim. What other habits set apart newer GLP-1 users from those who have been on the medication for a longer period of time? Our speakers will look at the different usage patterns and what these trends mean for businesses. Plus, they’ll dive into the growing interest in natural supplements and other products designed to support this new wave of health management. Tune in to learn:
- How consumer habits are shifting, from intense health-focused changes to more sustainable approaches
- How GLP-1 use varies across demographics like income and age—and what’s driving these differences
- The role of supplements and natural solutions in filling the gaps and supporting long-term wellness for GLP-1 users
Suzy
Smarter insights, faster decisions. With Suzy’s AI-powered, connected research platform, test more and guess less. In other words: assume nothing.
